BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29371975)

  • 1. The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells.
    Rudzinska M; Ledwon JK; Gawel D; Sikorska J; Czarnocka B
    Oncotarget; 2017 Dec; 8(69):114136-114155. PubMed ID: 29371975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
    Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Signature of Prospero Homeobox 1 (PROX1) in Follicular Thyroid Carcinoma Cells.
    Rudzińska M; Grzanka M; Stachurska A; Mikula M; Paczkowska K; Stępień T; Paziewska A; Ostrowski J; Czarnocka B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy.
    Rudzińska M; Czarnocka B
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
    Hoelting T; Siperstein AE; Clark OH; Duh QY
    J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
    Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
    Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.
    Ishii J; Yazawa T; Chiba T; Shishido-Hara Y; Arimasu Y; Sato H; Kamma H
    Endocrinology; 2016 Mar; 157(3):1289-98. PubMed ID: 26760117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
    Liu Y; Jiang C; Tan Y
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
    Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
    Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of prospero homeobox-1 on tumor cell behavior and prognosis in colorectal cancer.
    Park YL; Myung E; Park SY; Kim N; Oak CY; Myung DS; Cho SB; Lee WS; Kweon SS; Kim HS; Joo YE
    Am J Cancer Res; 2015; 5(11):3286-300. PubMed ID: 26807311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
    Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
    Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
    Miao X; Zhao Y
    Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt.
    O'Malley Y; Lal G; Howe JR; Weigel RJ; Komorowski RA; Shilyansky J; Sugg SL
    Surgery; 2012 Dec; 152(6):1218-24. PubMed ID: 23158188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
    Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
    Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
    Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
    Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
    Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
    Hoelting T; Siperstein AE; Duh QY; Clark OH
    J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma.
    Anania MC; Miranda C; Vizioli MG; Mazzoni M; Cleris L; Pagliardini S; Manenti G; Borrello MG; Pierotti MA; Greco A
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1591-600. PubMed ID: 23928665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.